Patients who combine tirzepatide with consistent movementeven 150 minutes weekly of moderate activityshow better weight maintenance than those relying on medication alone
GLP-1R agonists protect against Alzheimers disease by rewiring energy regulation
Meanwhile, GIP receptor activation can also enhance glucose-dependent insulin release through the AKT/PKB signaling pathway and promote -cell proliferation while inhibiting apoptosis, playing an important role in glucose regulation and insulin secretion (Regmi et al., 2024
Jessen L, Smith EP, Ulrich-Lai Y, et al
Start Your Weight Loss Journey with Doctronic's AI-Powered Care Ready to take the next step in your weight loss journey with tirzepatide
Addressing Stigma and Promoting Positive Messaging Nearly 70% of people taking GLP-1 medication have been asked about their use of weight-loss medication